Literature DB >> 27161659

The impact of insurance coverage and the family on pediatric diabetes management.

Sara E Watson1, Evan A Kuhl1, Michael B Foster1, Adetokunbo O Omoruyi1, Suzanne E Kingery1, Charles Woods2, Kupper A Wintergerst1.   

Abstract

BACKGROUND/
OBJECTIVE: The impact of family composition on glycemic control in children with type 1 diabetes remains unclear. We sought to evaluate the relationship between health insurance coverage, family composition, and insulin management, and assess their impact on glycemic control in a pediatric type 1 diabetes population.
METHODS: A retrospective chart review was completed for patients seen in the Pediatric Endocrinology Clinic at the University of Louisville in 2012.
RESULTS: The analysis included 729 patients with type 1 diabetes; 268 (37%) had public insurance while 461(63%) had private insurance. Compared with publicly insured patients, privately insured patients had higher rates of intensive insulin management with multiple daily injections (MDI) plans or pump devices (88 vs. 83.2%, p = 0.066) and lower HbA1c levels [8.57 vs. 9.39% (70 vs. 79 mmol/mol), p < 0.001]. Of the 729 patients, 243 were in single-adult homes (33%). Single-adult homes had higher HbA1c levels than two-adult homes, [9.3 vs. 8.6% (78 vs. 70 mmol/mol), p < 0.001]. Among publicly insured, there was no difference in HbA1c levels for single-adult vs. two-adult homes [9.4 (79 mmol/mol), p = 0.868]. For privately insured, patients in single-adult homes had higher HbA1c levels than peers in two-adult homes [9.2 vs. 8.4% (77 vs. 68), p < 0.001].
CONCLUSION: Insurance type and family composition have significant associative effects on glycemic control and insulin management that may be mitigated by insulin pump therapy. Identifying and addressing factors such as availability of resources, family education, and adult support and supervision, may help improve glycemic control in high-risk pediatric diabetes patients.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  family; insulin; insurance; type 1 diabetes

Mesh:

Substances:

Year:  2016        PMID: 27161659     DOI: 10.1111/pedi.12394

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  3 in total

1.  Risk of Microvascular Complications and Macrovascular Risk Factors in Early-Onset Type 1 Diabetes after at Least 10 Years Duration: An Analysis of Three Population-Based Cross-Sectional Surveys in Germany between 2009 and 2016.

Authors:  Thaddäus Tönnies; Anna Stahl-Pehe; Christina Baechle; Katty Castillo; Oliver Kuss; Rhuphine Yossa; Lena M E Lindner; Reinhard W Holl; Joachim Rosenbauer
Journal:  Int J Endocrinol       Date:  2018-04-01       Impact factor: 3.257

2.  Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey.

Authors:  Tiago Jeronimo Dos Santos; Chetankumar Dave; Sarah MacLeish; Jamie R Wood
Journal:  BMJ Open Diabetes Res Care       Date:  2021-11

3.  Comparison of Socioeconomic Disparities in Pump Uptake Among Children With Type 1 Diabetes in 2 Canadian Provinces With Different Payment Models.

Authors:  Jennifer M Ladd; Atul Sharma; Elham Rahme; Kristine Kroeker; Marjolaine Dubé; Marc Simard; Céline Plante; Claudia Blais; Marni Brownell; Celia Rodd; Meranda Nakhla
Journal:  JAMA Netw Open       Date:  2022-05-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.